NO872885D0 - 1,3,5-tritianderivater og fremgangsmaate for dens fremstilling. - Google Patents

1,3,5-tritianderivater og fremgangsmaate for dens fremstilling.

Info

Publication number
NO872885D0
NO872885D0 NO872885A NO872885A NO872885D0 NO 872885 D0 NO872885 D0 NO 872885D0 NO 872885 A NO872885 A NO 872885A NO 872885 A NO872885 A NO 872885A NO 872885 D0 NO872885 D0 NO 872885D0
Authority
NO
Norway
Prior art keywords
tritiander
derivatives
procedure
preparation
tritiander derivatives
Prior art date
Application number
NO872885A
Other languages
English (en)
Other versions
NO173389C (no
NO872885L (no
NO173389B (no
Inventor
Masashi Nagamine
Kunikazu Hiraga
Atsushi Sakai
Matazaemon Uchida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of NO872885D0 publication Critical patent/NO872885D0/no
Publication of NO872885L publication Critical patent/NO872885L/no
Priority to NO921307A priority Critical patent/NO175099C/no
Publication of NO173389B publication Critical patent/NO173389B/no
Publication of NO173389C publication Critical patent/NO173389C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D341/00Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO872885A 1986-07-15 1987-07-10 Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater NO173389C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO921307A NO175099C (no) 1986-07-15 1992-04-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16616786 1986-07-15

Publications (4)

Publication Number Publication Date
NO872885D0 true NO872885D0 (no) 1987-07-10
NO872885L NO872885L (no) 1988-01-18
NO173389B NO173389B (no) 1993-08-30
NO173389C NO173389C (no) 1993-12-08

Family

ID=15826315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872885A NO173389C (no) 1986-07-15 1987-07-10 Analogifremgangsm}te og mellomprodukter for fremstilling av tetrapeutisk aktive 1,3,5-tritianderivater

Country Status (14)

Country Link
US (2) US4816475A (no)
EP (1) EP0253370B1 (no)
JP (1) JPS63146870A (no)
KR (1) KR950003499B1 (no)
AU (1) AU596434B2 (no)
CA (1) CA1296728C (no)
DE (1) DE3788163T2 (no)
DK (1) DK365087A (no)
FI (1) FI90075C (no)
HU (1) HUT46904A (no)
IE (1) IE60984B1 (no)
IL (1) IL83171A (no)
NO (1) NO173389C (no)
NZ (1) NZ221032A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728235D0 (en) * 1987-12-02 1988-01-06 Sandoz Ltd Novel azole compounds
US5149844A (en) * 1989-10-20 1992-09-22 Air Products And Chemicals, Inc. Heterocyclic diorganotin catalysts for use in polyurethane systems
CN103003268A (zh) 2010-07-19 2013-03-27 先正达参股股份有限公司 作为杀微生物剂的异噁唑、异噻唑、呋喃以及噻吩化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492313A (en) * 1967-01-16 1970-01-27 Pfizer & Co C Novel derivatives of 1,3,5-trithiane
US3525751A (en) * 1967-03-27 1970-08-25 Syntex Corp Hormonal diphenyl methylol and benzhydrylidene derivatives
US3792043A (en) * 1971-12-02 1974-02-12 Squibb & Sons Inc Process for converting compounds containing a cyclic sulfur group to aldehydes or ketones
JPS5748980A (en) * 1980-09-05 1982-03-20 Mitsubishi Chem Ind Ltd Cyclopropanecarboxylic ester
ZA821644B (en) * 1981-03-25 1983-01-26 Expansia Sa Borane complexes

Also Published As

Publication number Publication date
IL83171A (en) 1992-07-15
KR950003499B1 (ko) 1995-04-13
IE60984B1 (en) 1994-09-07
NZ221032A (en) 1990-02-26
AU7568087A (en) 1988-01-21
HUT46904A (en) 1988-12-28
DE3788163D1 (de) 1993-12-23
IL83171A0 (en) 1987-12-31
AU596434B2 (en) 1990-05-03
KR880001629A (ko) 1988-04-25
EP0253370B1 (en) 1993-11-18
CA1296728C (en) 1992-03-03
FI90075C (fi) 1993-12-27
US5045562A (en) 1991-09-03
NO173389C (no) 1993-12-08
NO872885L (no) 1988-01-18
NO173389B (no) 1993-08-30
US4816475A (en) 1989-03-28
IE871902L (en) 1988-01-15
EP0253370A1 (en) 1988-01-20
FI90075B (fi) 1993-09-15
DE3788163T2 (de) 1994-03-10
JPS63146870A (ja) 1988-06-18
DK365087A (da) 1988-01-16
FI873116A0 (fi) 1987-07-14
FI873116A (fi) 1988-01-16
DK365087D0 (da) 1987-07-14

Similar Documents

Publication Publication Date Title
LV5742B4 (lv) 3,5-divalizvietoti pirokatehina atvasinajumi
NO875358D0 (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO870512D0 (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO872831D0 (no) Fremgangsmaate for fremstilling av nitrofuranderivater.
DK462187D0 (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
DE3763411D1 (de) 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate.
NO871052L (no) 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse.
DE3777997D1 (de) Piperidinderivate.
DE3761308D1 (de) 18-phenylestrane-derivate.
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
IT8620297A0 (it) Composti stabilizzanti eprocedimento per la loro preparazione.
DE3887281D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
DE3778624D1 (de) Glucosylmoranoline-derivate.
DE3765646D1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2-derivate.
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO864306D0 (no) Fremgangsmaate for fremstilling av 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
DE3888097D1 (de) 1,2,3,4-Tetrahydro-5-nitro-pyrimidin-Derivate.
DE3781831D1 (de) Aralkylimidazolderivate.
DE3780338D1 (de) Indenopyrimidin-derivate.
NO872885D0 (no) 1,3,5-tritianderivater og fremgangsmaate for dens fremstilling.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
DE3774759D1 (de) Alkenamid-derivate.
DE3785480D1 (de) Macrolid-derivate.